Harter Secrest & Emery LLP
N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
This invention provides a compound of formula AThe compound provided herein can affect the opening of, or otherwise modulate, voltage-gated potassium channels. The compound provided herein is useful for the treatment and prevention of diseases and disorders which are affected by activation or modulation of potassium ion channels. One such condition is seizure disorders.
Valeant Pharmaceuticals International
A A A A C
A61P A61P A61P A61P C07D
inventional inventional inventional inventional inventional
Huanming Jim Zhen Gary Lee Martha Alicia Ian Wayne Jean-Michel
Chen Wu Larson De La Rosa Cheney Vernier